Capitalizing hope: the commercial development of umbilical cord blood stem cell banking

Paul A Martin, Nik Brown, Andrew Turner

Research output: Contribution to journalArticle (Academic Journal)peer-review

76 Citations (Scopus)

Abstract

The creation of commercial cord blood banks rests on the promise of stem cell based regenerative medicine and marks the capitalization of human tissues within a future-oriented ?regime of hope?. This paper will present data from a survey of the international cord blood banking industry and will explore: (a) the way firms seek to commercialize cord blood as a new set of commodities; (b) the expectations and moral economy that are being constructed around this technology; and (c) how firms are acting as mediators of hope in what might be called a ?promissory bioeconomy?.
Original languageEnglish
Pages (from-to)127-143
Number of pages17
JournalNew Genetics and Society
Volume27
Issue number2
DOIs
Publication statusPublished - 2008

Fingerprint

Dive into the research topics of 'Capitalizing hope: the commercial development of umbilical cord blood stem cell banking'. Together they form a unique fingerprint.

Cite this